Back to top

earnings-outlook: Archive

Zacks Equity Research

All You Need to Know About Ellington Credit (EARN) Rating Upgrade to Buy

Ellington Credit (EARN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

EARNPositive Net Change

Zacks Equity Research

What Makes Seanergy Maritime Holdings (SHIP) a New Strong Buy Stock

Seanergy Maritime Holdings (SHIP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

SHIPNegative Net Change

Zacks Equity Research

What Makes Dell Technologies (DELL) a New Buy Stock

Dell Technologies (DELL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

DELLPositive Net Change

Zacks Equity Research

Interactive Brokers (IBKR) Upgraded to Strong Buy: Here's What You Should Know

Interactive Brokers (IBKR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

IBKRPositive Net Change

Zacks Equity Research

These 2 Computer and Technology Stocks Could Beat Earnings: Why They Should Be on Your Radar

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

DELLPositive Net Change GNRCPositive Net Change

Zacks Equity Research

Canaan (CAN) Reports Q1 Loss, Tops Revenue Estimates

Canaan (CAN) delivered earnings and revenue surprises of 73.33% and 16.58%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

CANNegative Net Change DSGXNegative Net Change

Zacks Equity Research

Applied Materials (AMAT) Q2 Earnings and Revenues Surpass Estimates

Applied Materials (AMAT) delivered earnings and revenue surprises of 6.09% and 2.04%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?

AMATNegative Net Change VEEVNegative Net Change

Zacks Equity Research

DXC Technology Company. (DXC) Q4 Earnings and Revenues Top Estimates

DXC Technology (DXC) delivered earnings and revenue surprises of 16.87% and 0.42%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

DXCNegative Net Change SCWXPositive Net Change

Zacks Equity Research

Copart, Inc. (CPRT) Q3 Earnings and Revenues Surpass Estimates

Copart (CPRT) delivered earnings and revenue surprises of 2.63% and 1.79%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?

CPRTPositive Net Change PAGSPositive Net Change

Zacks Equity Research

Globant (GLOB) Matches Q1 Earnings Estimates

Globant (GLOB) delivered earnings and revenue surprises of 0% and 0.06%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

GLOBPositive Net Change OKTANegative Net Change

Zacks Equity Research

Flowers Foods (FLO) Q1 Earnings and Revenues Miss Estimates

Flowers Foods (FLO) delivered earnings and revenue surprises of -5% and 0.10%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

FLONegative Net Change UNFIPositive Net Change

Zacks Equity Research

Doximity (DOCS) Q4 Earnings and Revenues Surpass Estimates

Doximity (DOCS) delivered earnings and revenue surprises of 25% and 1.37%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

DOCSNegative Net Change ICCMPositive Net Change

Zacks Equity Research

Costamare (CMRE) Upgraded to Strong Buy: What Does It Mean for the Stock?

Costamare (CMRE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

CMREPositive Net Change

Zacks Equity Research

All You Need to Know About Aptiv (APTV) Rating Upgrade to Strong Buy

Aptiv (APTV) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

APTVPositive Net Change

Zacks Equity Research

All You Need to Know About Passage Bio (PASG) Rating Upgrade to Buy

Passage Bio (PASG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

PASGNegative Net Change

Zacks Equity Research

Hanover Insurance (THG) Upgraded to Buy: Here's Why

Hanover Insurance (THG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

THGNegative Net Change

Zacks Equity Research

Camtek (CAMT) Moves to Strong Buy: Rationale Behind the Upgrade

Camtek (CAMT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CAMTPositive Net Change

Zacks Equity Research

What Makes ResMed (RMD) a New Strong Buy Stock

ResMed (RMD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

RMDNegative Net Change

Zacks Equity Research

StoneCo (STNE) Upgraded to Buy: What Does It Mean for the Stock?

StoneCo (STNE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

STNEPositive Net Change

Zacks Equity Research

All You Need to Know About Carrols Restaurant (TAST) Rating Upgrade to Buy

Carrols Restaurant (TAST) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

Milestone Pharmaceuticals (MIST) Upgraded to Buy: Here's What You Should Know

Milestone Pharmaceuticals (MIST) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

MISTNegative Net Change

Zacks Equity Research

Palmer Square Capital BDC Inc. (PSBD) Upgraded to Strong Buy: What Does It Mean for the Stock?

Palmer Square Capital BDC Inc. (PSBD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

PSBDPositive Net Change

Zacks Equity Research

Dillard's (DDS) Tops Q1 Earnings and Revenue Estimates

Dillard's (DDS) delivered earnings and revenue surprises of 19.89% and 1.19%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?

DDSPositive Net Change KSSNegative Net Change

Zacks Equity Research

Global Ship Lease (GSL) Tops Q1 Earnings and Revenue Estimates

Global Ship Lease (GSL) delivered earnings and revenue surprises of 8.12% and 5.19%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

GSLPositive Net Change EDRYNegative Net Change

Zacks Equity Research

Lightspeed Commerce Inc. (LSPD) Q4 Earnings and Revenues Surpass Estimates

Lightspeed POS (LSPD) delivered earnings and revenue surprises of 20% and 2.74%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

LSPDNegative Net Change ARBEPositive Net Change